Emerging Longevity Science

A drug to extend healthy lifespan in senior dogs is in regulatory review. It is not approved.

LOY-002 has cleared two of the three technical sections the FDA requires. That is real progress and it is not the same as a licence — a distinction the marketing around canine longevity does not always preserve.